Thu. 21 Mar 2024, 8:06am ET
Benzinga
Earnings, News
Landos Biopharma (NASDAQ:LABP) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.91) by 8.79 percent. This is a 23.85 percent increase over losses of $(1.30) per share from the same period last year.